Ambey Laboratories Limited
ListedSMEHealthcare / Pharmaceuticals · NSE
Ambey Laboratories, incorporated in 1985, is a leading agrochemical manufacturer specializing in crop protection solutions and has been a key player in the industry for nearly four decades. Operating from its ISO 9001:2015 and ISO 14001:2015 certified facility in Behror, Rajasthan, the company is renowned for producing and supplying 2,4-D base chemicals and a diverse range of agrochemical formulations, including herbicides, insecticides, and fungicides. Its product portfolio features 2,4-D Acid 98% TC, 2,4-D Sodium 95% SP, 2,4-D Amine, Chlorpyriphos, Thiamethoxam, Pretilachlor, Metribuzin, Hexaconazole, and Metalaxyl, among others, catering to domestic and international markets. With a workforce of 220 employees as of October 31, 2023, Ambey Laboratories serves prominent corporate clients such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd., reinforcing its position as a trusted supplier in the agrochemical sector.
Price Band
₹65 – ₹68
Issue Size
₹44.68 Cr
Lot Size
2000 shares
GMP
₹28
+41.2%
Est. Listing
₹96
at current GMP
Subscribed
159.71x
overall
Open
4 Jul 2024
Close
8 Jul 2024
Allotment
9 Jul 2024
Refund
10 Jul 2024
Demat Credit
11 Jul 2024
Listing
11 Jul 2024
Last updated 12 days ago
Overall Subscription
159.71x
Total Demand
QIB Multiplier
61.90x
Institutions & Funds
NII / HNI
210.13x
High Net-Worth
Retail (RII)
194.18x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 1,252,000 | 77,496,000 | 61.90x |
| NIB | 936,000 | 196,686,000 | 210.13x |
| RETAIL | 2,184,000 | 424,088,000 | 194.18x |
| Total | 4,372,000 | 698,270,000 | 159.71x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 1,150 | 223,307 | 194.18x |
| HNIs (10L +) | 7 | 1,471 | 210.13x |
| HNIs (2-10L) | 35 | 7,355 | 210.13x |
| Total Applications | 1,192 | 232,133 | 194.74x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Ambey Laboratories Limited Public Issue & Market Profile
Ambey Laboratories Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹44.68 Crores. The shares are offered at a price band of ₹65 to ₹68 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Bidding & Quota Instructions:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Allotment Reconciliation Schedule:
Following the close of bidding on 2024-07-08, the basis of allotment is scheduled to be finalized on 2024-07-09. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Ambey Laboratories Limited IPO GMP today?
The latest Grey Market Premium (GMP) for Ambey Laboratories Limited IPO is ₹28 per equity share. Based on the upper price band of ₹65 to ₹68 per equity share, the estimated listing price is ₹96 (+41.2% expected listing gain).
What is the expected profit per lot for Ambey Laboratories Limited IPO?
With a lot size of 2000 shares and current GMP of ₹28, the expected profit per application lot is approx ₹56,000 (+41.2% gain). Minimum application cost is approx ₹1,36,000.
What is the issue size and price band for Ambey Laboratories Limited IPO?
The Ambey Laboratories Limited IPO aggregate issue size is ₹44.68 Crores with an equity price band set at ₹65 to ₹68 per equity share. The retail lot size is 2000 shares requiring a minimum capital outlay of approx. ₹1,36,000.
How can I check Ambey Laboratories Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 159.71x (Retail: 194.18x, QIB: 61.90x, NII: 210.13x). You can track live multiples directly on our dedicated subscription page.
Where and when will Ambey Laboratories Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2024-07-09. Investors can verify status using PAN card or application number.
When is the listing date for Ambey Laboratories Limited IPO?
Ambey Laboratories Limited shares are scheduled to list on NSE on 2024-07-11.